Aug 01, 2023 / NTS GMT
Brian Leedman - Respiri Limited - Non-Executive Director
I'm actually -- I've been a biotech entrepreneur for a number of years. Michael just talked about a really good company and also Imugene. I'm actually the co-founder of Imugene, which I think is capped at about an $800 million or something now, isn't it, Mike? $600 million, sorry.
ResApp Health is a company that I also founded. There's a lot of familiar faces in the room here. That's a company that got sold to Pfizer in September last year for a great deal of money. I mean it was a great outcome for shareholders. But it certainly had its ups and downs for our member, first presenting at this conference back in 2015 for ResApp and the share price was only $0.02, with a market cap of $7 million. It ends up being acquired for $180 million.
So a good journey. But one of the things that ResApp failed to do, much to my great disappointment, was it never got FDA approval. And FDA is obviously the entree into the biggest market in the world in the US and that was definitely a catalyst for the share price of ResApp to collapse at one point. Now
Respiri Ltd at TechKnow-Gold Coast Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers